Evidence map›Paper›PMID 41188588›Full record

ArticleCommunications chemistry2025

Thermo-responsive targeting of polymeric micelles by controlling the cellular uptake based on the change of their surface arginine density.

Sota Yamada, Eita Sasaki, Hisashi Ohno, Kenichi Nagase, Kenjiro Hanaoka

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sota YamadaFaculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5083-5650
Eita SasakiFaculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8202-4465
Hisashi OhnoFaculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.ORCID http://orcid.org/0009-0008-0177-782X
Kenichi NagaseFaculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-6575-0107
Kenjiro HanaokaFaculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan. khanaoka@keio.jp.ORCID http://orcid.org/0000-0003-0797-4038

Funding

Japan Agency for Medical Research and Development (AMED) JP23ak0101182h0003, JP23wm0325046s0103 and JP23gm1510012s0201MEXT | Japan Society for the Promotion of Science (JSPS) JP23H02613, JP21H05262 and JP23K17389
6 · The paper itself

Abstract

Stimulus-responsive nanocarriers are good candidates for targeted drug delivery. Herein, inspired by the existence of a clear threshold number of arginine residues in oligoarginines for cell-penetrating peptide (CPP) activity, we developed a strategy to control the CPP activity by changing the local arginine density for thermo-responsive targeting. We constructed polymeric micelles whose shell consists of a thermo-responsive polymer based on N-isopropylacrylamide, with a low density of arginine moieties (named Arg-TRM). At physiological temperature (37 °C), internalization of Arg-TRM into cells was small and comparable to that of micelle without arginine. In contrast, upon heating at 42 °C, the arginine density on the micellar surface was increased by thermo-responsive shrinkage of the shell, thereby switching on the CPP activity and enabling efficient cellular uptake. The response of Arg-TRM at 42 °C occurred within a few minutes and the intracellular uptake was rapidly enhanced from 5 min after the heating. This response was transient, thus enabling reversible control of the enhancement by heating. As proof-of-concept, we show that intravenously administered Arg-TRM was effectively accumulated in one ear of a normal mouse by local heating. These results indicate that Arg-TRM is a promising drug carrier for on-demand targeted drug delivery in response to mild external heating.

Identifiers

PMID41188588
PMCPMC12586460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.